Spackman Media Group Artist Kim Sang-Kyung Stars In TVN K-Drama, POONG, THE JOSEON PSYCHIATRIST, Topping Audience Ratings On Premiere Day In Korea

4 years ago

Starring Spackman Media Group artist Kim Sang-kyung, POONG, THE JOSEON PSYCHIATRIST took first place in audience ratings for its time…

AMTD Digital Inc.: Thank you note to investors and our response to our latest ADS price performance

4 years ago

NEW YORK & SINGAPORE & HONG KONG--(BUSINESS WIRE)--AMTD Digital Inc. (“AMTD Digital” or the “Company”) (NYSE: HKD), a comprehensive one-stop…

Egnyte Solidifies Investment in India with New Head of India

4 years ago

Sachin Shetty will manage operations in India to help accelerate growth for the team in the region MUMBAI, India &…

Valaris Reports Second Quarter 2022 Results

4 years ago

Continued Strong Operational Performance – 97% Revenue Efficiency in 2Q 2022 Four Floater Reactivation Projects Completed in Advance of Multi-Year…

NOVATION launches DataVio solution, saving businesses time and resources on manual data processing

4 years ago

HONG KONG SAR - Media OutReach - 2 August 2022 - NOVATION, Hong Kong’s globally trusted leader in data security…

UD Trucks Introduces Its Newest Upgrades to Quon: Driving Better Efficiency for A More Sustainable Future

4 years ago

SINGAPORE - Media OutReach - 2 August 2022 - UD Trucks today introduced its new, upgraded Quon – a more…

OctaFX celebrates its 11th anniversary and reveals its brand philosophy

4 years ago

OctaFX is celebrating its 11th anniversary! Here’s what the broker achieved over the years and the core elements of the…

TalariaX Rebrands As SendQuick Pte Ltd To Strengthen Presence In Messaging Notification Arena

4 years ago

SINGAPORE - Media OutReach - 2 August 2022 - SendQuick Pte Ltd is pleased to announce that they have officially…

Scrut Automation Launches ‘Risk Management’ for Cloud-Based Companies

4 years ago

Scrut Risk Management is designed to help customers manage their risks more effectively. The tool streamlines risk assessments by automating…

InnoCare Announces First Subject Dosed in Clinical Trial of TYK2 JH2 Allosteric Inhibitor ICP-488 in China

4 years ago

BEIJING--(BUSINESS WIRE)--InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today…